Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Commissioning Update

6 Feb 2014 07:00

RNS Number : 3971Z
Graphene NanoChem PLC
06 February 2014
 

For Immediate Release

6 February 2014

Graphene NanoChem plc

("Graphene NanoChem" or the "Group")

 

Commissioning Update

 

Graphene NanoChem (AIM: GRPH), the performance nanochemicals and advanced materials company, is pleased to announce the recommencement of production, on 29 January 2014, at its Senawang speciality chemicals facility (the "Facility"). The Facility produces the Group's PlatAmber and PlatClear second-generation biofuels and the base fluid for the Group's graphene-enhanced drilling fluid for the oilfield services market, of which the Company anticipates the first bulk deployment by the end of H1 2014.

The Facility was shut down in October 2013 in order to permit an increase in capacity from 80,000 MT per annum to 120,000 MT per annum. The expansion work has been concluded satisfactorily and production has recommenced on a phased basis, with full capacity production expected, as scheduled, by April 2014. In addition, work has been completed on the layer esterification unit, which is expected to reduce costs substantially. Furthermore, the Group expects to be able to deliver further improvements to historic production uptime levels, and thus modest margin improvements, through the installation of an upgraded conversion unit by the end of February 2014.

 

For further information:

 

Graphene NanoChem

Tel: +603 2282 3080

Jespal Deol, Chief Executive Officer

Panmure Gordon (NOMAD and Broker)

Callum Stewart / Tom Salvesen

Tel: +44 (0) 20 7886 2500

Tom Nicholson

Tel: +65 8614 7553

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Edwards / Fiona Henson / Helen Greenwood

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGGZVKLGDZM
Date   Source Headline
5th Dec 20062:39 pmRNSHolding(s) in Company
1st Dec 20062:48 pmRNSHolding(s) in Company
30th Nov 20069:20 amRNSHolding(s) in Company
29th Nov 200612:07 pmRNSHolding(s) in Company
23rd Nov 20061:43 pmRNSEGM Statement
21st Nov 20067:00 amRNSChange of Registered Address
2nd Nov 200612:33 pmRNSDirector/PDMR Shareholding
1st Nov 20062:10 pmRNSDirector/PDMR Shareholding
1st Nov 200611:40 amRNSSchedule 1 - Biofutures Int
30th Oct 20067:01 amRNSAcquisition
30th Oct 20067:01 amRNSRestoration - Biofutures Intl
22nd Sep 20067:00 amRNSMaiden Interim Results
25th Aug 20063:00 pmRNSAppt. of Finance Director
28th Jul 20062:43 pmRNSConditional Agreement
19th Jun 20069:56 amRNSHolding(s) in Company
1st Jun 200611:45 amRNSSuspension - Biofutures Intl
1st Jun 200611:45 amRNSre Press Speculation
24th May 20063:08 pmRNSHolding(s) in Company
24th May 20067:01 amRNSHolding(s) in Company
17th May 20062:45 pmRNSHolding(s) in Company
17th May 200610:19 amRNSHolding(s) in Company
15th May 200611:38 amRNSHolding(s) in Company
15th May 200610:56 amRNSHolding(s) in Company
11th May 200612:10 pmRNSHolding(s) in Company
5th May 20061:39 pmRNSDirector shareholding
5th May 200611:10 amRNSHolding(s) in Company
5th May 20069:00 amRNSPlacing & Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.